Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Cyprus
100%
Reimbursement
75%
Thalassemia
50%
Luspatercept
50%
Managed Entry Agreements
50%
Budget Impact Analysis
50%
Budget Impact
27%
β-Thalassemia Major (β-TM)
18%
Dropout Rate
18%
Expert Opinion
14%
Country Context
8%
Operational Context
8%
Effective Operation
8%
Scientific Committee
8%
Operational Framework
8%
Cutout
8%
National Health System
8%
Innovative Drugs
8%
Small Countries
8%
Healthcare Sector
8%
Area Cover
8%
Narrative Synthesis
8%
Health Care Markets
8%
Cooperation Principle
8%
Hospital Costs
8%
Budget Transfers
8%
Technical Parameters
8%
Recent Introduction
8%
Policy Analysis
8%
Ideal Testing
8%
Knowledge Gaps
8%
Payers
6%
Phase I Trial
6%
Financial Feasibility
6%
Treatment Discontinuation
6%
Pharmaceutical Expenditure
6%
Armamentarium
6%
Thalassemia Management
6%
Opinion Consensus
6%
Therapeutic Landscapes
6%
Clinical Data
6%
Clinical Trial Data
6%
Budget Impact Model
6%
One-way Sensitivity Analysis
6%
Best Supportive Care
6%
World Data
6%
Affixes
6%
Societal Perspective
6%
Medicine and Dentistry
Luspatercept
50%
Thalassemia
50%
Health System
50%
Knowledge Gap
50%
Cooperation
50%
Thalassemia Major
18%
Clinical Trial
12%
Supportive Care
6%
Real-World Data
6%
